Key Drivers
- Positive EBITDA
- Thin margins
- Working-capital strain
AIAI Summary
ScanSource's investment thesis now hinges less on top‑line distribution growth and more on whether Intelisys and specialty technology mix can materially expand gross profit and stabilize recurring cash flow — execution on integration and working‑capital improvement is the primary determinant of upside. Monitor consecutive quarters of GP% expansion, falling DSO/inventory days, and sustained Intelisys recurring orders; misses on those metrics or rising reserves would signal downside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Positive EBITDA
- •Thin margins
- •Working-capital strain
SCSC generates consistent EBITDA and free cash flow with modest leverage and reasonable liquidity, but thin net margins, large working capital needs, and declining cash pose profitability and cash-conversion risks.
Price Behavior
Key Price Behavior Insights:
- •Below last-month SMA
- •Near-oversold RSI
- •Support clustering
SCSC is trading below its last-month SMA with RSI near oversold, suggesting downside momentum but a possible mean-reversion bounce if buyers defend the ~$34.30 support and push price back above the mid-$36s–$37.5–$38.1 resistance zone.
Price sits below last-month average while
Sentiment & News
Key News Insights:
- •Investor outreach
- •Specialty technologies
- •HR leadership
ScanSource is accelerating investor outreach while rapidly adding senior leadership—naming a Specialty Technologies president and a CHRO—to sharpen its converged-solutions strategy and organizational capacity.
These moves should bolster investor confidence and execution on specialty solutions by deepening leadership and people capabilities
Similar Companies in Technology
Other companies in the same sector with AI ratings